Morbid Obesity
Metabolic·MeSH: Obesity, Morbid
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Lidocaine | Cidara Therapeutics, Inc. (CDTX) |
Phase 4(1)
| Drug | Company |
|---|---|
| Lidocaine | Valneva SE (VALN) |
Frequently asked questions
How many drugs are in development for Morbid Obesity?
BioSniper tracks 2 drugs in development for Morbid Obesity across 2 companies.
How many clinical trials target Morbid Obesity?
There are 2 clinical trials targeting Morbid Obesity tracked by BioSniper.
What is the prevalence of Morbid Obesity?
The estimated prevalence of Morbid Obesity is approximately 42000.0 per 100,000 population.
Deep-dive into Morbid Obesity
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis